Recent VVOS News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/08/2026 05:15:06 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/02/2026 09:44:43 PM
- Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan • GlobeNewswire Inc. • 12/16/2025 01:45:00 PM
- Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST • GlobeNewswire Inc. • 12/15/2025 10:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2025 10:12:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/19/2025 09:45:04 PM
- Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025 • GlobeNewswire Inc. • 11/19/2025 09:20:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/19/2025 09:06:19 PM
- Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call • GlobeNewswire Inc. • 11/19/2025 01:30:00 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2025 09:01:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2025 09:58:16 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/24/2025 09:22:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 09:20:50 PM
- Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device • GlobeNewswire Inc. • 09/30/2025 12:30:00 PM
- Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment • GlobeNewswire Inc. • 09/17/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2025 08:52:50 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/12/2025 08:50:44 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/05/2025 09:06:57 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/25/2025 08:46:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/20/2025 08:05:35 PM
- Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update • GlobeNewswire Inc. • 08/19/2025 08:20:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2025 08:06:33 PM
- Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call • GlobeNewswire Inc. • 08/19/2025 12:30:00 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2025 08:15:12 PM
Xalles Holdings Announces Management Changes • XALL • Jan 12, 2026 8:46 AM
One World Products Enters 2026 Positioned for Disciplined Growth as Isiah Enterprises • OWPC • Jan 8, 2026 12:22 PM
ConnectM Acquires 40% of Sun Solar, Strengthening Balance Sheet and Expanding National Solar & Storage Footprint in Multi-Billion Dollar U.S. Residential Solar & Storage Market • CNTM • Jan 7, 2026 9:00 AM
EVTV Executes Transformational AZIO AI Acquisition Framework at $3.00 Per Share • EVTV • Jan 6, 2026 7:00 AM
Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace • FITY • Jan 5, 2026 1:00 PM
DRCR Enters a New Phase of Growth • DRCR • Dec 31, 2025 12:04 PM
